The resistance of cancer cells to molecularly targeted therapies, promotion of the epithelial-mesenchymal transition (EMT), and increased invasion of cancer cells are all caused by the crosstalk between Notch and EGFR signalling 30. This evidence concerns the gene EGFR and cancer.